<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00681447</url>
  </required_header>
  <id_info>
    <org_study_id>protocol 15</org_study_id>
    <nct_id>NCT00681447</nct_id>
  </id_info>
  <brief_title>Treatment of Chronic Low Back and Lower Extremity Pain</brief_title>
  <official_title>A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Lumbar Interlaminar Epidural Injections in Lumbar Disc Herniation, and Discogenic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pain Management Center of Paducah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pain Management Center of Paducah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To demonstrate clinically significant improvements in patients undergoing lumbar
           interlaminar epidurals. Improvement will be assessed in relation to the clinical outcome
           measures of pain and function.

        2. To evaluate and compare the adverse event profile in all patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To demonstrate clinically significant improvement or lack thereof with the lumbar interlaminar epidural patients with or without steroids.</measure>
    <time_frame>Patients will return for follow-up visits at 3, 6, 12, 18, and 24 months post-treatment. The recruitment period is estimated as 24 months with an anticipated study duration of 48 months.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate differences in outcomes in patients receiving steroids compared to those patients randomized to the local anesthetic group who did not receive steroids.</measure>
    <time_frame>Patients will return for follow-up visits at 3, 6, 12, 18, and 24 months post-treatment. The recruitment period is estimated as 24 months with an anticipated study duration of 48 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate and compare the adverse event profile in all patients.</measure>
    <time_frame>Patients will return for follow-up visits at 3, 6, 12, 18, and 24 months post-treatment. The recruitment period is estimated as 24 months with an anticipated study duration of 48 months.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lumbar interlaminar epidural injection with local anesthetic only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lumbar Interlaminar Epidural Injection with local anesthetic wiht 6 mg of non-particulate Celestone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lumbar Interlaminar Epidural</intervention_name>
    <description>Lumbar interlaminar epidural injections under fluoroscopy
Epidural tray and needle
Drugs:
0.5% Xylocaine and non-particulate Celestone</description>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_label>Group II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lumbar Interlaminar Epidural injection</intervention_name>
    <description>Lumbar interlaminar epidural injections under fluoroscopy
Epidural tray and needle
Drugs:
0.5% Xylocaine and non-particulate Celestone</description>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_label>Group II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects of at least 18 years of age

          -  Subjects with a history of chronic, function-limiting chronic low back pain of at
             least 6 months in duration

          -  Subjects who are able to give voluntary, written informed consent to participate in
             this investigation

          -  Subjects who, in the opinion of the PI, are able to understand this investigation,
             co-operate with the investigational procedures, and are willing to return to the
             center for all the required post-operative follow-ups

          -  Subjects have not had recent surgical procedures within the last 3 months.

        Exclusion Criteria:

          -  Cauda Equina symptoms and/or compressive radiculopathy

          -  Narcotic use of no greater than hydrocodone 100 mg/day, methadone of 60 mg, or
             morphine 180 mg, or dose equivalent

          -  Uncontrolled major depression or uncontrolled psychiatric disorders

          -  Uncontrolled or acute medical illnesses including coagulopathy, renal insufficiency,
             chronic liver dysfunction, progressive neurological deficit, urinary sphincter
             dysfunction, infection, increased intracranial pressure, pseudotumor cerebri,
             intracranial tumors, unstable angina, and severe chronic obstructive pulmonary
             disease.

          -  Chronic severe conditions that could interfere with the interpretations of the outcome
             assessments for pain and bodily function

          -  Women who are pregnant or lactating

          -  Subjects who have participated in a clinical study with an investigational product
             within 30 days of enrollment

          -  Patients with multiple complaints involving concomitant hip osteoarthritis, due to the
             overlap of pain complaints

          -  Inability to achieve appropriate positioning and inability to understand informed
             consent and protocol

          -  History of adverse reaction to local anesthetic or anti-inflammatory drugs and history
             of gastrointestinal bleeding or ulcers

          -  Previous surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laxmaiah Manchikanti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ambulatory Surgery Center, Paducah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ambulatory Surgery Center</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2008</study_first_submitted>
  <study_first_submitted_qc>May 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2008</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pain Management Center of Paducah</investigator_affiliation>
    <investigator_full_name>Laxmaiah Manchikanti, MD</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>lumbar disc herniation</keyword>
  <keyword>discogenic pain</keyword>
  <keyword>lumbar interlaminar epidural</keyword>
  <keyword>injections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

